News

ASML's (NASDAQ: ASML) stock price dropped 4% on Oct. 18 after the Dutch semiconductor equipment maker posted its third-quarter earnings report. Its revenue rose 15% year over year to 6.67 billion

U.S. companies have created more value for their investors than those of any other nation throughout history. The country's commitment to free markets empowers the cream to rise to the top, and

There are no two ways about it: Nvidia (NASDAQ: NVDA) stock has been an unqualified success for long-term shareholders. The stock has gained more than 10,730% over the past decade, and that's not

When cryptocurrency investors can let go of the desire for fast profits, that may be when the best long-term gains can be achieved. It's easy to lose sight of this with a fast-moving coin like Shiba

There aren't many metrics where home improvement retailer Lowe's (NYSE: LOW) can claim supremacy over its bigger rival, Home Depot (NYSE: HD). But the record of dividend increases is one of them

Most people become eligible to claim their Social Security benefits at age 62, and nearly 30% of people opted to start receiving their monthly checks as soon as possible in 2021.

While getting your

Few trends have been capturing the attention of investors since this decade began quite like the rise of electric vehicles (EVs). According to Fortune Business Insights, global EV revenue is

JPMorgan Chase's (NYSE: JPM) quarterly earnings beat analysts' revenue and earnings expectations and illustrated the strength of the company's fortress balance sheet, which was well-positioned for

The S&P 500 sits about 9% below its all-time high at the moment, meaning the index is 9 percentage points away from bull market territory by the most conservative definition. That threshold is worth

Fool.com contributor Parkev Tatevosian evaluates the response from C3.ai (NYSE: AI) management and gives his opinion on the short sellers' comments and the prospects for a short squeeze.  

*Stock

Dutch semiconductor bellwether ASML (NASDAQ: ASML) sent a dire warning to the semiconductor industry when it released its third-quarter 2023 results on Wednesday.

The company, which is known for

Tech investors will probably remember 2023 as the year that artificial intelligence (AI) became a primary focus of investors. Thanks to ChatGPT, investors bought into stocks that leveraged AI for

For nearly six decades as CEO of conglomerate Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), Warren Buffett has been dazzling Wall Street with his investing prowess. Although Buffett is fallible

There is a dual tailwind expected to push the semiconductor industry higher over the next five to seven years. First, the overall demand for chips is rising as the world goes digital, cars get

Advances in artificial intelligence (AI) have led to rising share prices in a broad cross-section of the market this year, but no stock has been more profoundly impacted than Nvidia (NASDAQ: NVDA)

Medicare provides health coverage to millions of older Americans. But the costs seniors incur under Medicare can easily change from one year to the next.

In 2024, the standard Medicare Part B

Both Enphase Energy (NASDAQ: ENPH) and SolarEdge (NASDAQ: SEDG) have been huge long-term winning investments. But more recently, they're down sharply off their highs. In this video, Motley Fool

Many investors love growth stocks for their potential to supercharge a portfolio -- and these shares often do this particularly well during times of market strength. We're not in a bull market

Image source: The Motley Fool.

Intuitive Surgical (NASDAQ: ISRG)Q3 2023 Earnings CallOct 19, 2023, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Image source: The Motley Fool.

WD-40 (NASDAQ: WDFC)Q4 2023 Earnings CallOct 19, 2023, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Badger Meter (NYSE: BMI) stock gained 3% on Thursday, following the smart-water technology specialist's release of better-than-expected results for the third quarter of 2023. The quarter's revenue

Shares of Redfin (NASDAQ: RDFN) were down 13.6% this week at Thursday's close, according to data provided by S&P Global Market Intelligence, amid a barrage of worrisome real estate industry

A new royalty deal was the fuel that powered biotech PTC Therapeutics (NASDAQ: PTCT) stock to a 15% gain on Thursday. That arrangement, which covers PTC's spinal muscular atrophy (SMA) treatment